card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials

With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials
Home / Insights / With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials

Spectral Flow Cytometry Special Report

 

Authors:

  • Megan McCausland, IQVIA Laboratories
  • Christopher Groves, SCYM(ASCP)CM, IQVIA Laboratories
  • Tania Nevers, Ph.D., Bristol Myers Squibb
  • Yi-Dong Lin, Ph.D., GlaxoSmithKline
  • Vilma Decman, Ph.D., GlaxoSmithKline

 
The use of spectral Flow Cytometry has the potential to significantly increase the data collected through clinical studies. Recent technology advancements and increased availability of fluorochromes have resulted in a dramatic rise in the complexity and dimensionality of flow cytometry panels. While increasing the panel size enables detection of a broader spectrum of markers and subpopulations, even in small biological samples, it also introduces several obstacles in panel design, optimization, and downstream data processing and interpretation.

 

In this collaborative special report in Bioanalysis, the authors share their experiences and methodologies for developing high-dimensional panels for the Aurora spectral flow cytometer to facilitate enhanced clinical sample analysis.

 

Read the report.